TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa.
about
The interleukin-17 cytokine family: critical players in host defence and inflammatory diseasesThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunityInnate immune signaling in defense against intestinal microbesThe Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human PrimatesDNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-AdjuvantRegulation of mammalian siderophore 2,5-DHBA in the innate immune response to infectionEarly production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.Yersinia pseudotuberculosis supports Th17 differentiation and limits de novo regulatory T cell induction by directly interfering with T cell receptor signalingRegulation of Toll-like receptor 5 gene expression and function on mucosal dendritic cells.Interactions between the intestinal microbiota and innate lymphoid cells.Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice.Linking genetic variation in human Toll-like receptor 5 genes to the gut microbiome's potential to cause inflammation.Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis.Role of murine intestinal interleukin-1 receptor 1-expressing lymphoid tissue inducer-like cells in Salmonella infection.Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells.Regulation of innate and adaptive immunity by the commensal microbiota.Mechanisms controlling Th17 cytokine expression and host defenseAssessment of Lactobacillus gasseri as a candidate oral vaccine vectorInterleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense.Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease.Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword.Single-cell sequencing provides clues about the host interactions of segmented filamentous bacteria (SFB).A Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections.Host-microbiota interactions in inflammatory bowel disease.NADPH oxidases: an overview from structure to innate immunity-associated pathologies.Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease.IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary DiseaseViral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels.Sublingual immunotherapy as an alternative to induce protection against acute respiratory infectionsInterleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.Intestinal lamina propria dendritic cells maintain T cell homeostasis but do not affect commensalism.Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22IL-17 family member cytokines: regulation and function in innate immunity.Control of epithelial cell function by interleukin-22-producing RORγt+ innate lymphoid cells.Recent advances in IL-22 biology.Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells.Toll-like receptor signaling and regulation of intestinal immunity.Utilizing bacterial flagellins against infectious diseases and cancers.
P2860
Q24594675-FF6FD5E8-9525-43F1-ACC7-FFDCF6207FF0Q26750673-43ADBF73-7168-446B-BA1B-6CE8F56912A8Q27002611-DC333BB5-D2E3-4C48-A997-4E56097C2E65Q28548012-6F271240-BA19-4BDA-99A4-3D6167C3B4E6Q30223578-AF95E022-9B61-4BF3-8C08-DD87605C6994Q33702939-F3E6AD75-C6E8-4F1E-AFBD-C44947E61D9DQ33728489-F5F21BF3-37EF-4F23-9F3C-7C48E80AA4A5Q33854513-7639C5A1-CA31-40CD-B379-714F485E9E6AQ34251277-3CD4D188-2EC6-4514-810C-32F16C206DBDQ34397537-C117AECD-73F0-4997-A3EB-E9AA55C889E4Q34619950-96C0F051-0F4C-45F6-9D64-E138BCCF600AQ34656930-8665B75A-106C-4B61-98F7-8236710760FEQ34740026-8E4553F9-4EF3-4BBC-A0F9-B8FF1E928E46Q34764304-6FC3C710-BF7D-459F-8813-1F9ED84EA1C2Q34969719-E8643746-F24C-473D-B292-3C7D8935B4FDQ34991544-D4FC2DA3-9E54-4AD4-9BA6-24D9C695C1CBQ35028444-9313E8EA-E833-4413-943E-42F5BECFC498Q35096758-4E9930D8-D9EF-4224-B65E-21B31E370141Q35530209-A7CCBCA5-2D21-428A-B6D0-7CA9093E04FCQ35784100-2A512470-442B-4826-B792-76C5C33DE449Q35785264-BC77A903-975F-48E4-86E6-2FDD96E11153Q35906051-5C67CBB2-9C3E-4376-A747-5264E623CF19Q36021748-32AFAA1D-E382-4C28-BA30-1317B3194AFAQ36075829-BF81503F-8BF9-4AD0-A14C-48F8A48B646CQ36295242-75ACA53B-71D7-4103-B728-8A835536D718Q36302873-588DDE02-FBEA-478D-84D5-F608D313A9B9Q36390314-A778C946-626E-4D49-AA3F-CE130DCA5514Q36540978-66BC8DA6-B30C-4E68-AE68-CD307DB0B2E9Q36677605-BC3A0CF2-E1A4-4F24-AFE0-3A353FE0BE62Q36733882-BC8CDA7F-30D3-4A81-AC64-4770ACB2AFAEQ36788003-41256BB9-2864-403A-88DA-373D7576A6D8Q36911822-53792441-AAF8-453C-B3D7-7A0223A1E297Q37194987-45D2C89D-6C2B-4C8F-B6A7-17626F35E268Q37611966-B1263EDE-6A45-4AFA-8E8C-5220800F9145Q37809207-A191F979-EB2E-41BE-8C3C-B45889188ADFQ37851543-A9A430ED-81A3-4BBF-B27A-2172AE2C0AC1Q37851777-568B4A3F-FE3B-4018-A7E1-081AF80B9C24Q37929639-9A97A906-9850-43BE-A118-61D575488C41Q38075402-8D4D0D50-FF1E-429C-8DE4-869D92282169Q38166277-9EBF374C-D4B7-412D-9FB3-4DD140A227B2
P2860
TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3
@nl
TLR5 signaling stimulates the ...... ne cells in spleen and mucosa.
@ast
TLR5 signaling stimulates the ...... ne cells in spleen and mucosa.
@en
type
label
TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3
@nl
TLR5 signaling stimulates the ...... ne cells in spleen and mucosa.
@ast
TLR5 signaling stimulates the ...... ne cells in spleen and mucosa.
@en
altLabel
TLR5 Signaling Stimulates the ...... une Cells in Spleen and Mucosa
@en
prefLabel
TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3
@nl
TLR5 signaling stimulates the ...... ne cells in spleen and mucosa.
@ast
TLR5 signaling stimulates the ...... ne cells in spleen and mucosa.
@en
P2093
P2860
P50
P356
P1476
TLR5 signaling stimulates the ...... ne cells in spleen and mucosa.
@en
P2093
Arndt Benecke
François Erard
Hélène Leger
Isabel Ferrero
Julie Bertout
Laure Dumoutier
Laure Janot
Pascal Songhet
P2860
P304
P356
10.4049/JIMMUNOL.1000115
P407
P50
P577
2010-06-21T00:00:00Z